There is currently insufficient evidence supporting cTnI as a biological diagnostic of DCM, and it is mostly utilized as an auxiliary signal, despite the fact that cTnI levels in the blood of DCM patients are higher than in the diabetic group. Here, TNNI3 is linked to familial dilated cardiomyopathy.